2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 3ÀÏÂ÷ : 2023-09-23
±³À°ÀÏÀÚ : 2023-09-23
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º ±×·£µåº¼·ë
±³À°ÁÖÁ¦ : 2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 3ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ : kshf3@kshf.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í [»çÀüµî·Ï]±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ: 70,000¿ø / ÀüÀÓÀÇ,Á¦¾à °ü·Ã Á¾»çÀÚ: 30,000¿ø / Àü°øÀÇ, °£È£»ç, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ), ±ºÀÇ°ü: 10,000¿ø / 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á [ÇöÀåµî·Ï]±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ: 80,000¿ø / ÀüÀÓÀÇ,Á¦¾à °ü·Ã Á¾»çÀÚ: 40,000¿ø / Àü°øÀÇ, °£È£»ç, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ), ±ºÀÇ°ü: 20,000¿ø / 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 09:00~09:15 Heart Failure with Preserved Ejection Fraction: Current Landscape and Challenges Ahead Peter Seferovic(University of Belgrade)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 09:15~09:30 Precision Medicine in Heart Failure: Where do we stand now? Andrew Coats(Heart Research Institute)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 09:30~09:45 Clinical implications and Challenges of Frailty in Heart Failure Giuseppe Rosano(St George¡¯s University Medical School of London)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 09:45~10:00 Emerging Therapeutic Options in Heart Failure: What¡¯s on the horizon? John Teerlink(University of California San Francisco)
Åä·Ð 09¿ù 23ÀÏ ±×·£µåº¼·ë 10:00~10:20 Discussion ¹ÚÁøÁÖ, ½Å¼ºÈñ, Àå¼¼¿ë(¼¿ïÀÇ´ë, ÀÎÇÏÀÇ´ë, °æºÏÀÇ´ë)
ÈÞ½Ä 09¿ù 23ÀÏ ±×·£µåº¼·ë 10:20~10:50 Break ()
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 10:50~11:05 Coexisting frailty with heart failure Amina Rakisheva(Scientific Institution of Cardiology)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 11:05~11:20 Frailty assessment methods in heart failure ±è±¤ÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 11:20~11:35 When and how to address palliative care? Palliative care referral criteria ÃÖÈ¿ÀÎ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 11:35~11:50 How to provide palliative care in heart failure Shogo Oishi(Mahoshi Hospital)
Åä·Ð 09¿ù 23ÀÏ ±×·£µåº¼·ë 11:50~12:10 Discussion ±è´ë¿ë, ±èÁöÈñ, ÀÌÀº¹Ì, È«´ÙÀ§(ÀÎÇÏÀÇ´ë, °¡Å縯ÀÇ´ë, ¿ø±¤ÀÇ´ë, ¼º±Õ°üÀÇ´ë)
½Ä»ç 09¿ù 23ÀÏ ±×·£µåº¼·ë 12:10~13:10 Lunch ()
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 13:10~13:25 4 Types of Plagiarism & when is it too much? À¯¿µ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 13:25~13:40 npg Digital medicine: the success story of new journal ±è±¤ÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 13:40~13:55 ChatGPT: AI as author À±Ã¶Èñ(¼¿ï´ë, µ¿¹°¸é¿ªÇÐ)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 13:55~14:10 What is a right direction for the IJHF ¹Ú¼º¹Ì(°í·ÁÀÇ´ë)
Åä·Ð 09¿ù 23ÀÏ ±×·£µåº¼·ë 14:10~14:30 Discussion ±Ç¿ÀÈÆ, ¹ÚÁøÁÖ, ¿ÀÇüö, Á¤¿íÁø(ÇѼֺ´¿ø, ¼¿ïÀÇ´ë, Áß¾ÓÀÇ´ë, °¡ÃµÀÇ´ë)
ÈÞ½Ä 09¿ù 23ÀÏ ±×·£µåº¼·ë 14:30~15:00 Break ()
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 15:00~15:15 Keynote lecture: Lessons from the CHART-2 Study Yasuhiko Sakata(National Cerebral and Cardiovascular Center)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 15:15~15:30 KorHF III registry: baseline characteristics and outcome compared with previous registries Á¶ÇöÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 15:30~15:45 Clinical inertia and long-term outcomes in HF patients ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ±×·£µåº¼·ë 15:45~16:00 The Comparative Effectiveness Between ARNI and RAS blockade in Patient with HFrEF (PARADE-HF): The Real-World Evidence Focused on Medication Adherence Á¶µ¿Çõ(°í·ÁÀÇ´ë)
Åä·Ð 09¿ù 23ÀÏ ±×·£µåº¼·ë 16:00~16:20 Discussion ¼Áö¿ø, ±è´Ù·¡, ±è¼¼Àº, º¯¿µ¼·(¿¬¼¼ÀÇ´ë, ¼º±Õ°üÀÇ´ë, ¿¬¼¼ÀÇ´ë, ÀÎÁ¦ÀÇ´ë)